Cargando…
Hydroxychloroquine/mycophenolate mofetil/rituximab: Human coronavirus infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758350/ http://dx.doi.org/10.1007/s40278-022-08844-z |
Ejemplares similares
-
Hydroxychloroquine/mycophenolate mofetil/prednisone: SARS-CoV-2 infection: case report
Publicado: (2021) -
Mycophenolate mofetil: Coronavirus disease-19 infection: case report
Publicado: (2021) -
Refractory pemphigus vulgaris treated with rituximab and mycophenolate
mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014) -
Immune globulin/mycophenolate mofetil/rituximab: Breakthrough COVID-19: 2 case reports
Publicado: (2022) -
Mycophenolate-mofetil/prednisolone/rituximab: Treatment-related osteopenia and candidiasis: 7 case reports
Publicado: (2022)